Cross presentation of antigen by dendritic cells: mechanisms and implications for immunotherapy.
Dendritic cells (DCs) possess the specialized potential to present exogenously derived antigen to cytotoxic T lymphocytes to elicit an immune response. This process, termed cross presentation, is crucial in the generation of immune response to viruses, tumors and in autoimmune disease. The ability o...
Үндсэн зохиолчид: | Sachamitr, P, Fairchild, P |
---|---|
Формат: | Journal article |
Хэл сонгох: | English |
Хэвлэсэн: |
2012
|
Ижил төстэй зүйлс
Ижил төстэй зүйлс
-
iPS cells reprogrammed from primary dendritic cells provide an abundant source of immunostimulatory dendritic cells for use in immunotherapy
-н: Horton, C, зэрэг
Хэвлэсэн: (2019) -
Induced pluripotent stem cells: challenges and opportunities for cancer immunotherapy.
-н: Sachamitr, P, зэрэг
Хэвлэсэн: (2014) -
Directed differentiation of human induced pluripotent stem cells into dendritic cells displaying tolerogenic properties and resembling the CD141+ subset
-н: Sachamitr, P, зэрэг
Хэвлэсэн: (2018) -
Induced pluripotent stem cells: Challenges and opportunities for cancer immunotherapy
-н: Patty eSachamitr, зэрэг
Хэвлэсэн: (2014-04-01) -
STING-activating dendritic cell-targeted nanovaccines that evoke potent antigen cross-presentation for cancer immunotherapy
-н: Nguyen Thi Nguyen, зэрэг
Хэвлэсэн: (2024-12-01)